Summary

The Middle East and Africa gastrointestinal endoscopy market, is expected to reach USD 621,822.86 thousand by 2032 from USD 472,995.43 thousand in 2024, growing at a substantial CAGR of 3.6% in the forecast period of 2025 to 2032.
Market Segmentation:
Middle East and Africa Gastrointestinal Endoscopy Market, Product (Gastrointestinal Endoscopes & Systems, Gastrointestinal Endotherapy), Application (Treatment And Diagnosis), Procedure Type (Colonoscopy, Gastroscopy, Duodenoscopy, Enteroscopy, Sigmoidoscopy And Others), Usability (Reusable, Disposable/ Single Use), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Laboratories, And Others), Distribution Channel (Direct Tender, Retail Sales, And Others), Country (Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, And Rest Of Middle East And Africa) -Industry Trends & Forecast To 2032

Overview of the Middle East and Africa Gastrointestinal Endoscopy are:

Driver

• Rising Prevalence of Gastrointestinal Disorders

Restrain

• High Cost of Equipment and Procedures
Opportunity

• Growing Emphasis on Early Colorectal Cancer Detection

Market Players:

The key market players for Middle East and Africa Gastrointestinal Endoscopy are listed below:

• Medtronic (Ireland)
• Stryker (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• Cook (U.S.)
• CONMED Corporation (U.S.)
• STERIS (U.S.)
• Henry Schein, Inc. (U.S.)
• CapsoVision, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Olympus Corporation (Japan)
• Hoya Corporation (Japan)
• Smith+Nephew (UK)
• INTROMEDIC (South Korea)

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 93
1.1 OBJECTIVES OF THE STUDY 93
1.2 MARKET DEFINITION 93
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET 93
1.4 LIMITATIONS 95
1.5 MARKETS COVERED 95
2 MARKET SEGMENTATION 98
2.1 MARKETS COVERED 98
2.2 GEOGRAPHICAL SCOPE 99
2.3 YEARS CONSIDERED FOR THE STUDY 100
2.4 CURRENCY AND PRICING 100
2.5 DBMR TRIPOD DATA VALIDATION MODEL 101
2.6 MULTIVARIATE MODELLING 104
2.7 PRODUCT LIFELINE CURVE 105
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 106
2.9 DBMR MARKET POSITION GRID 107
2.10 VENDOR SHARE ANALYSIS 108
2.11 MARKET END USER COVERAGE GRID 109
2.12 SECONDARY SOURCES 110
2.13 ASSUMPTIONS 110
3 EXECUTIVE SUMMARY 111
4 PREMIUM INSIGHTS 116
4.1 PESTAL ANALYSIS 117
4.2 PORTERS FIVE FORCES ANALYSIS 118
4.3 INDUSTRY INSIGHTS 119
4.3.1 MICRO AND MACROECONOMIC FACTORS 119
4.3.2 PENETRATION AND GROWTH PROSPECT MAPPING 119
4.3.3 KEY PRICING STRATEGIES 119
4.3.4 COST ANALYSIS BREAKDOWN 119
4.3.5 TECHNOLOGY ROADMAP 119
4.3.6 OPPUTUNITY MAP ANALYSIS 120
4.3.7 PRICING ANALYSIS 120
4.3.8 COMPETITOR’S MODEL ANALYSIS 120
4.3.9 HEALTHCARE ECONOMY 120
4.3.9.1 HEALTHCARE EXPENDITURE 120
4.3.9.2 CAPITAL EXPENDITURE 120
4.3.9.3 CAPEX TRENDS 121
4.3.9.4 CAPEX ALLOCATION 121
4.3.9.5 FUNDING SOURCES 121
4.3.9.6 INDUSTRY BENCHMARKS 121
4.3.9.7 GDP RATIO IN OVERALL GDP 121
4.3.9.8 HEALTHCARE SYSTEM STRUCTURE 122
4.3.9.9 GOVERNMENT POLICIES 122
4.3.9.10 ECONOMIC DEVELOPMENT 122
4.4 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 123
4.4.1 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 123
4.4.2 VENDOR SELECTION CRITERIA DYNAMICS 124
4.4.3 IMPACT ON SUPPLY CHAIN 124
4.4.3.1 RAW MATERIAL PROCUREMENT 125
4.4.3.2 MANUFACTURING AND PRODUCTION 125
4.4.3.3 LOGISTICS AND DISTRIBUTION 126
4.4.3.4 PRICE PITCHING AND POSITION OF MARKET 126
4.4.4 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 127
4.4.4.1 SUPPLY CHAIN OPTIMIZATION 127
4.4.4.2 JOINT VENTURE ESTABLISHMENTS 128
4.4.5 IMPACT ON PRICES 129
4.4.6 REGULATORY INCLINATION 129
4.4.6.1 GEOPOLITICAL SITUATION 130
4.4.6.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 130
4.4.6.3 FREE TRADE AGREEMENTS 131
4.4.6.4 ALLIANCES ESTABLISHMENTS 131
4.4.6.5 STATUS ACCREDITATION (INCLUDING MFTN) 132
4.4.6.6 DOMESTIC COURSE OF CORRECTION 132
4.4.6.7 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 133
4.4.6.8 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES/INDUSTRIAL PARKS 134
4.4.7 PRICE INDEX 134
4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS 135
4.6 SUPPLY CHAIN ECOSYSTEM 137
4.7 COMPANY EVALUATION QUADRANT 138
5 REGULATORY COMPLIANCE 139
5.1 REGULATORY AUTHORITIES 139
5.2 REGULATORY CLASSIFICATIONS 140
5.3 REGULATORY SUBMISSIONS 141
5.4 INTERNATIONAL HARMONIZATION 141
5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 141
5.6 REGULATORY CHALLENGES AND STRATEGIES 141
6 MARKET OVERVIEW 142
6.1 DRIVERS 144
6.1.1 RISING PREVALENCE OF GASTROINTESTINAL DISORDERS 144
6.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI ENDOSCOPY 145
6.1.3 TECHNOLOGICAL ADVANCEMENTS ENHANCING GI ENDOSCOPY PROCEDURES 146
6.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 147
6.2 RESTRAINTS 148
6.2.1 HIGH COST OF EQUIPMENT AND PROCEDURES 148
6.2.2 RISK OF PROCEDURE-RELATED COMPLICATIONS 149
6.3 OPPORTUNITIES 150
6.3.1 GROWING EMPHASIS ON EARLY COLORECTAL CANCER DETECTION 150
6.3.2 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 151
6.3.3 INCREASING PREVALENCE AND ADVANCEMENTS IN PERSONALIZED THERAPEUTIC ENDOSCOPY 152
6.4 CHALLENGES 153
6.4.1 LIMITED ACCESS TO GI ENDOSCOPY IN RURAL AREAS 153
6.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 154
7 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET, BY PRODUCT 155
7.1 OVERVIEW 156
7.2 GASTROINTESTINAL ENDOSCOPES & SYSTEMS 159
7.2.1 ENDOSCOPES 161
7.2.1.1 COLONOSCOPES 162
7.2.1.2 GASTROSCOPES 162
7.2.1.3 DUODENOSCOPES 162
7.2.1.4 ENTEROSCOPES 162
7.2.1.5 SIGMOIDOSCOPES 162
7.2.1.6 RESECTOSCOPES 162
7.2.2 FLEXIBLE 163
7.2.3 RIGID 163
7.2.4 SEMI-RIGID 163
7.2.4.1 VIDEO 164
7.2.4.2 FIBRE 164
7.2.4.3 ULTRASONIC 164
7.2.5 VISUALIZATION SYSTEMS 165
7.2.5.1 FLUORESCENCE IMAGING SYSTEMS 165
7.2.5.1.1 NIR LIGHT FLUORESCENCE IMAGING SYSTEM 166
7.2.5.1.2 WHITE LIGHT FLUORESCENCE IMAGING SYSTEM 166
7.2.5.1.3 UV LIGHT FLUORESCENCE IMAGING SYSTEMS 166
7.2.5.1.4 CONFOCAL LASER ENDOSCOPY IMAGING SYSTEMS 166
7.2.5.1.5 PROBE-BASED CLE (PCLE) 167
7.2.5.1.6 BUILT-IN DEVICE CLE (ECLE) 167
7.2.5.2 HIGH DEFINITION (HD) VISUALIZATION SYSTEMS 168
7.2.5.2.1 2D SYSTEMS 168
7.2.5.2.2 3D SYSTEMS 168
7.2.5.3 STANDARD DEFINITION (SD) VISUALIZATION SYSTEMS 169
7.2.5.3.1 ENDOSCOPIC ULTRASONOGRAPHY SYSTEMS 169
7.2.5.3.2 CAPSULE ENDOSCOPES 169
7.2.5.3.3 ULTRASOUND DEVICE 169
7.3 GASTROINTESTINAL ENDOTHERAPY 170
7.3.1 ERCP DEVICES 172
7.3.2 BIOPSY DEVICE 172
7.3.3 STENTING AND DILATION DEVICE 172
7.3.4 HOMEOSTASIS DEVICES 172
7.3.4.1 LIGATION DEVICES 173
7.3.4.2 PROBES 173
7.3.4.3 SCLEROTHERAPY NEEDLES 173
7.3.5 RETRIEVAL DEVICES 174
7.3.6 CAMERA HEAD 174
7.3.7 ANTI-REFLUX DEVICES 174
7.3.7.1 TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) DEVICES 174
7.3.7.2 TRANSESOPHAGEAL RADIOFREQUENCY (RF) ANTI-REFLUX DEVICES 174
7.3.8 OTHERS 175
8 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET, BY PROCEDURE TYPE 176
8.1 OVERVIEW 177
8.2 COLONOSCOPY 180
8.3 GASTROSCOPY 181
8.4 DUODENOSCOPY 181
8.5 ENTEROSCOPY 182
8.6 SIGMOIDOSCOPY 182
8.7 OTHERS 183
9 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET, BY USABILITY 184
9.1 OVERVIEW 185
9.2 REUSABLE 188
9.3 DISPOSABLE/ SINGLE USE 189
10 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET, BY APPLICATION 190
10.1 OVERVIEW 191
10.2 TREATMENT 194
10.3 DIAGNOSIS 195
11 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET, BY END USER 196
11.1 OVERVIEW 197
11.2 HOSPITALS 201
11.3 AMBULATORY SURGICAL CENTERS 202
11.4 SPECIALTY CLINICS 203
11.5 LABORATORIES 203
11.6 OTHERS 204
12 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET, BY DISTRIBUTION CHANNEL 205
12.1 OVERVIEW 206
12.2 DIRECT TENDER 209
12.3 RETAIL SALES 210
12.4 OTHERS 210
13 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET, BY REGION 211
13.1 MIDDLE EAST AND AFRICA 213
13.1.1 SOUTH AFRICA 227
13.1.2 SAUDI ARABIA 240
13.1.3 U.A.E 253
13.1.4 EGYPT 266
13.1.5 ISRAEL 278
13.1.6 KUWAIT 291
13.1.7 REST OF MIDDLE EAST AND AFRICA 304
14 MIDDLE EAST AND AFRICA GASTROINTESTINAL ENDOSCOPY MARKET: COMPANY LANDSCAPE 305
14.1 COMPANY SHARE ANALYSIS: GLOBAL 305
15 SWOT ANALYSIS 306
16 COMPANY PROFILES 307
16.1 OLYMPUS CORPORATION 307
16.1.1 COMPANY SNAPSHOT 307
16.1.2 REVENUE ANALYSIS 307
16.1.3 COMPANY SHARE ANALYSIS 308
16.1.4 PRODUCT PORTFOLIO 308
16.1.5 RECENT DEVELOPMENT/NEWS 310
16.2 FUJIFILM HOLDINGS CORPORATION 311
16.2.1 COMPANY SNAPSHOT 311
16.2.2 REVENUE ANALYSIS 311
16.2.3 COMPANY SHARE ANALYSIS 312
16.2.4 PRODUCT PORTFOLIO 312
16.2.5 RECENT DEVELOPMENTS/NEWS 313
16.3 MEDTRONIC 315
16.3.1 COMPANY SNAPSHOT 315
16.3.2 REVENUE ANALYSIS 315
16.3.3 COMPANY SHARE ANALYSIS 316
16.3.4 PRODUCT PORTFOLIO 316
16.3.5 RECENT DEVELOPMENTS/NEWS 318
16.4 JOHNSON & JOHNSON SERVICES, INC. 319
16.4.1 COMPANY SNAPSHOT 319
16.4.2 REVENUE ANALYSIS 319
16.4.3 COMPANY SHARE ANALYSIS 320
16.4.4 PRODUCT PORTFOLIO 320
16.4.5 RECENT DEVELOPMENTS 320
16.5 STRYKER 321
16.5.1 COMPANY SNAPSHOT 321
16.5.2 REVENUE ANALYSIS 321
16.5.3 COMPANY SHARE ANALYSIS 322
16.5.4 PRODUCT PORTFOLIO 322
16.5.5 RECENT DEVELOPMENT 323
16.6 AMBU AS 324
16.6.1 COMPANY SNAPSHOT 324
16.6.2 REVENUE ANALYSIS 324
16.6.3 PRODUCT PORTFOLIO 325
16.6.4 RECENT DEVELOPMENTS/NEWS 326
16.7 ANX ROBOTICS 327
16.7.1 COMPANY SNAPSHOT 327
16.7.2 PRODUCT PORTFOLIO 327
16.7.3 RECENT DEVELOPMENTS/NEWS 328
16.8 BOSTON SCIENTIFIC CORPORATION 329
16.8.1 COMPANY SNAPSHOT 329
16.8.2 REVENUE ANALYSIS 329
16.8.3 PRODUCT PORTFOLIO 330
16.8.4 RECENT DEVELOPMENT 332
16.9 CAPSOVISION, INC. 333
16.9.1 COMPANY SNAPSHOT 333
16.9.2 PRODUCT PORTFOLIO 333
16.9.3 RECENT DEVELOPMENTS/NEWS 334
16.10 CONMED CORPORATION 335
16.10.1 COMPANY SNAPSHOT 335
16.10.2 PRODUCT PORTFOLIO 336
16.10.3 RECENT DEVELOPMENTS 339
16.11 COOK 340
16.11.1 COMPANY SNAPSHOT 340
16.11.2 PRODUCT PORTFOLIO 340
16.11.3 RECENT DEVELOPMENT/NEWS 342
16.12 DAICHUAN MEDICAL 343
16.12.1 COMPANY SNAPSHOT 343
16.12.2 PRODUCT PORTFOLIO 343
16.12.3 RECENT DEVELOPMENT 343
16.13 ERBE ELEKTROMEDIZIN GMBH 344
16.13.1 COMPANY SNAPSHOT 344
16.13.2 PRODUCT PORTFOLIO 344
16.13.3 RECENT DEVELOPMENT 346
16.14 GONGJIANG ENDOSCOPY INSTRUMENTS CO., LTD 347
16.14.1 COMPANY SNAPSHOT 347
16.14.2 PRODUCT PORTFOLIO 347
16.14.3 RECENT DEVELOPMENT 347
16.15 HENRY SCHEIN, INC. 348
16.15.1 COMPANY SNAPSHOT 348
16.15.2 REVENUE ANALYSIS 348
16.15.3 PRODUCT PORTFOLIO 349
16.15.4 RECENT DEVELOPMENT 349
16.16 HOYA CORPORATION. 350
16.16.1 COMPANY SNAPSHOT 350
16.16.2 REVENUE ANALYSIS 350
16.16.3 PRODUCT PORTFOLIO 351
16.16.4 RECENT DEVELOPMENT 353
16.17 INTROMEDIC 354
16.17.1 COMPANY SNAPSHOT 354
16.17.2 PRODUCT PORTFOLIO 354
16.17.3 RECENT DEVELOPMENT 354
16.18 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD 355
16.18.1 COMPANY SNAPSHOT 355
16.18.2 PRODUCT PORTFOLIO 355
16.18.3 RECENT DEVELOPMENT 357
16.19 JINSHAN SCIENCE & TECHNOLOGY 358
16.19.1 COMPANY SNAPSHOT 358
16.19.2 PRODUCT PORTFOLIO 358
16.19.3 RECENT DEVELOPMENT/NEWS 360
16.20 KLS MARTIN GROUP 361
16.20.1 COMPANY SNAPSHOT 361
16.20.2 PRODUCT PORTFOLIO 361
16.20.3 RECENT DEVELOPMENT 363
16.21 LABORIE 364
16.21.1 COMPANY SNAPSHOT 364
16.21.2 PRODUCT PORTFOLIO 364
16.21.3 RECENT DEVELOPMENT 367
16.22 MECANMEDICAL 368
16.22.1 COMPANY SNAPSHOT 368
16.22.2 PRODUCT PORTFOLIO 368
16.22.3 RECENT DEVELOPMENT 369
16.23 MICRO-TECH ENDOSCOPY 370
16.23.1 COMPANY SNAPSHOT 370
16.23.2 PRODUCT PORTFOLIO 370
16.23.3 RECENT DEVELOPMENT 372
16.24 MITRA INDUSTRIES PVT. LTD. 373
16.24.1 COMPANY SNAPSHOT 373
16.24.2 PRODUCT PORTFOLIO 373
16.24.3 RECENT DEVELOPMENT 374
16.25 OVESCO ENDOSCOPY AG 375
16.25.1 COMPANY SNAPSHOT 375
16.25.2 PRODUCT PORTFOLIO 375
16.25.3 RECENT DEVELOPMENT 377
16.26 SHAILI ENDOSCOPY 379
16.26.1 COMPANY SNAPSHOT 379
16.26.2 PRODUCT PORTFOLIO 379
16.26.3 RECENT DEVELOPMENT 381
16.27 SMITH+NEPHEW 382
16.27.1 COMPANY SNAPSHOT 382
16.27.2 REVENUE ANALYSIS 382
16.27.3 PRODUCT PORTFOLIO 383
16.27.4 RECENT DEVELOPMENT 383
16.28 SONOSCAPE MEDICAL CORP. 384
16.28.1 COMPANY SNAPSHOT 384
16.28.2 REVENUE ANALYSIS 385
16.28.3 PRODUCT PORTFOLIO 385
16.28.4 RECENT DEVELOPMENT/NEWS 387
16.29 STERIS 388
16.29.1 COMPANY SNAPSHOT 388
16.29.2 REVENUE ANALYSIS 388
16.29.3 PRODUCT PORTFOLIO 389
16.29.4 RECENT DEVELOPMENT 390
16.30 TELEFLEX INCORPORATED. 391
16.30.1 COMPANY SNAPSHOT 391
16.30.2 REVENUE ANALYSIS 391
16.30.3 PRODUCT PORTFOLIO 392
16.30.4 RECENT DEVELOPMENT 393
17 QUESTIONNAIRE 394